Barei, F., Le Pen, C. and Simoens, S. (2012) “From generic to biosimilar drugs: why take an innovative pace?”, Farmeconomia. Health economics and therapeutic pathways, 13(3S), pp. 21–27. doi: 10.7175/fe.v13i3S.328.